Document is current
Any future updates will be listed below
-
Authors
Song, Kyu Jin https://orcid.org/0000-0003-2546-1981
Choi, Seunghyuk https://orcid.org/0000-0003-3600-1868
Kim, Kwoneel https://orcid.org/0000-0002-4221-3421
Hwang, Hee Sang
Chang, Eunhyong
Park, Ji Soo
Shim, Seok Bo
Choi, Seunghwan
Heo, Yong Jin
An, Woo Ju
Yang, Dae Yeol
Cho, Kyung-Cho https://orcid.org/0000-0003-0483-9543
Ji, Wonjun
Choi, Chang-Min
Lee, Jae Cheol
Kim, Hyeong-ryul
Yoo, Jiyoung
Ahn, Hee-Sung https://orcid.org/0000-0003-2241-6536
Lee, Gang-Hee
Hwa, Chanwoong
Kim, Seoyeon https://orcid.org/0000-0001-9184-7087
Kim, Kyunggon
Kim, Min-Sik https://orcid.org/0000-0001-7317-5360
Paek, Eunok https://orcid.org/0000-0003-3655-9749
Na, Seungjin https://orcid.org/0000-0002-5159-2048
Jang, Se Jin https://orcid.org/0000-0001-8239-4362
An, Joon-Yong https://orcid.org/0000-0001-8839-6297
Kim, Kwang Pyo https://orcid.org/0000-0003-0095-3787
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (2019M3E5D3071921)
- License Information
-
More Information
Article History
Received: 2 November 2023
Accepted: 6 November 2024
First Online: 23 November 2024
Competing interests
: Kwang Pyo Kim is the CEO of NioBiopharmaceuticals, Inc. Se Jin Jang is the chief technology officer of SG Medical, Inc. All other authors declare no competing interests.
